Core Insights - The report titled "China Neurological Disease Report 2024" was jointly released by multiple medical institutions under the guidance of the National Health Commission, covering 15 types of neurological diseases including cerebrovascular diseases and Parkinson's disease [1] - Breakthroughs have been achieved in brain-machine interface (BMI) research for treatment-resistant epilepsy, Parkinson's disease, amyotrophic lateral sclerosis, and spinal cord injuries [1] - The first global clinical trial of an epidural brain-machine interface began in October 2023, in collaboration with Tsinghua University, aiming to validate the effectiveness and safety of invasive BMI treatment options [1] Group 1 - The National Center for Neurological Diseases has completed the implantation of BMIs in 32 patients with quadriplegia, capturing brain signals to simulate normal physiological conduction [3] - The BMI technology shows significant potential in the medical health field, providing new treatment hopes and rehabilitation pathways for a large patient population suffering from neurological diseases [5] - The use of non-invasive BMIs is expected to explore human brain activity and dynamic changes, contributing to understanding aging mechanisms and enhancing elderly functionality [7]
神经系统疾病患者迎来“曙光” 我国脑机接口研究取得突破性进展
Yang Shi Wang·2025-11-02 02:40